Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+10.75%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$88.2B
AUM Growth
+$1.61B
(+1.9%)
Cap. Flow
-$4.61B
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
1,976
New
330
Increased
444
Reduced
869
Closed
67
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$349M |
| 2 |
TSMC
TSM
|
+$331M |
| 3 |
Genuine Parts
GPC
|
+$319M |
| 4 |
Nextracker
NXT
|
+$71.7M |
| 5 |
Blue Owl Capital
OWL
|
+$69.1M |
Top Sells
| 1 |
RTX Corp
RTX
|
+$383M |
| 2 |
ConocoPhillips
COP
|
+$378M |
| 3 |
Archer Daniels Midland
ADM
|
+$295M |
| 4 |
Merck
MRK
|
+$134M |
| 5 |
Paycom
PAYC
|
+$133M |
Sector Composition
| 1 | Technology | 25.56% |
| 2 | Healthcare | 13.98% |
| 3 | Financials | 12.4% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Talos Energy
TALO
$1.72B
| $795K | ﹤0.01% |
57,078
-2,608
| -4% | -$36.3K |
|
1352
Natural Resource Partners
NRP
$1.35B
| $794K | ﹤0.01% |
8,634
-394
| -4% | -$36.2K |
|
1353
Kimball Electronics
KE
$735M
| $792K | ﹤0.01% |
36,600
| – | – |
|
|
CTO
1354
CTO Realty Growth
CTO
$561M
| $788K | ﹤0.01% |
46,500
| – | – |
|
1355
Karyopharm Therapeutics
KPTI
$53.8M
| $755K | ﹤0.01% |
33,333
+8,000
| +32% | +$181K |
|
1356
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
| $754K | ﹤0.01% |
4,124
-4,665
| -53% | -$853K |
|
1357
Bio-Rad Laboratories Class A
BIO
$7.49B
| $746K | ﹤0.01% |
2,158
| – | – |
|
1358
Vishay Precision Group
VPG
$396M
| $742K | ﹤0.01% |
21,000
-14,910
| -42% | -$527K |
|
1359
Acadia Realty Trust
AKR
$2.54B
| $729K | ﹤0.01% |
42,846
+9,342
| +28% | +$159K |
|
1360
First Citizens BancShares
FCNCA
$25.2B
| $718K | ﹤0.01% |
439
-514
| -54% | -$840K |
|
1361
InvenTrust Properties
IVT
$2.28B
| $715K | ﹤0.01% |
27,820
-10
| -0% | -$257 |
|
|
CIO
1362
City Office REIT
CIO
$280M
| $714K | ﹤0.01% |
137,000
| – | – |
|
1363
Kosmos Energy
KOS
$832M
| $714K | ﹤0.01% |
119,715
-5,467
| -4% | -$32.6K |
|
1364
Cleveland-Cliffs
CLF
$5.62B
| $708K | ﹤0.01% |
31,148
+8,085
| +35% | +$184K |
|
1365
Liberty Global Class C
LBTYK
$3.99B
| $708K | ﹤0.01% |
40,132
| – | – |
|
1366
J.M. Smucker
SJM
$11.7B
| $708K | ﹤0.01% |
5,625
+617
| +12% | +$77.6K |
|
1367
VEON
VEON
$3.56B
| $703K | ﹤0.01% |
29,290
| – | – |
|
1368
Bunge Global
BG
$16.5B
| $698K | ﹤0.01% |
6,806
+525
| +8% | +$53.8K |
|
1369
Pebblebrook Hotel Trust
PEB
$1.36B
| $690K | ﹤0.01% |
44,784
-2,038
| -4% | -$31.4K |
|
1370
American Axle
AXL
$704M
| $686K | ﹤0.01% |
93,200
| – | – |
|
1371
MINISO
MNSO
$7.73B
| $678K | ﹤0.01% |
33,048
-23,795
| -42% | -$488K |
|
1372
Mersana Therapeutics
MRSN
$36.7M
| $672K | ﹤0.01% |
6,000
| – | – |
|
1373
Brown & Brown
BRO
$30.5B
| $665K | ﹤0.01% |
7,654
-74
| -1% | -$6.43K |
|
1374
Campbell Soup
CPB
$9.98B
| $661K | ﹤0.01% |
14,867
-1,883
| -11% | -$83.7K |
|
1375
Allogene Therapeutics
ALLO
$246M
| $656K | ﹤0.01% |
146,779
| – | – |
|